Corcept Therapeutics Inc
CORT· Nasdaq
Released Nov 7, 2019, after the close
10-Q filed Nov 7, 2019, 38 days after period end · 0001628280-19-013716
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $81.51M | $64.45M | $42.76M | $21.73M |
| Net Income | $26.34M | $17.75M | $13.76M | $2.59M |
| EPS Diluted |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| $0.22 |
| $0.14 |
| $0.11 |
| $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.